Some school districts, including MSCS, have what's called a self-funded health plan. That means the employer pays for ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The Dasman Diabetes Institute has reduced diabetes medications for patients by 50 percent through its Diabetes Overcome ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

There are three types of diabetes: type 1 (usually childhood onset), type 2 (usually adult onset), and gestational (during ...

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

The federal government has tapped a panel of five experts to craft the path toward a universal pharmacare program. Dr.

(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...